Pooja & Yashoda, IJPSR, 2014; Vol. 5(7): E-ISSN: ; P-ISSN:

Similar documents
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Hypertension and Diabetes Status Bangladesh Demographic and Health Survey

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

St Lucia Diabetes and Hypertension Screening and Disease Management Programs

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

Guidelines for the management of hypertension in patients with diabetes mellitus

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

How To Know If You Have Microalbuminuria

How To Determine The Prevalence Of Microalbuminuria

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Diabetic Nephropathy

Health Insurance Affects Diagnosis and Control of Hypercholesterolemia and Hypertension Among Adults Aged 20 64: United States,

Hypertension and Diabetes

Understanding diabetes Do the recent trials help?

Main Effect of Screening for Coronary Artery Disease Using CT

Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda - omdurman

How To Know If Low Protein Diet Is Beneficial For Kidney Health

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration

Blood Pressure. Blood Pressure (mm Hg) pressure exerted by blood against arterial walls. Blood Pressure. Blood Pressure

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

Human Clinical Study for Free Testosterone & Muscle Mass Boosting

Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: /ijmsph Received Date: Accepted Date:

InDependent Diabetes Trust

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )

Mississippi Delta Health Collaborative Mississippi State Department of Health 1

HIGH BLOOD PRESSURE AND YOUR KIDNEYS

INSULIN REQUIREMENT IN DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE DUE TO DIABETIC NEPHROPATHY (DN)

Prognostic impact of uric acid in patients with stable coronary artery disease

Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires

Coronary Heart Disease (CHD) Brief

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.

African Americans & Cardiovascular Diseases

Type 1 Diabetes ( Juvenile Diabetes)

MY TYPE 2 DIABETES NUMBERS

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Antihypertensive Drug Management to Achieve Systolic Blood Pressure <120 mmhg in SPRINT

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement

PREVENTING CHRONIC DISEASE

High Blood Pressure and Kidney Disease

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

Renal Disease in Type 2 Diabetes Mellitus

Short Term Effects of Coconut Water and Cocoa on Blood Pressure

Absolute cardiovascular disease risk assessment

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Racial and ethnic disparities in type 2 diabetes

Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group.

The Value of the Laboratory. Suzanne Carasso, MBA, MT (ASCP) Director, Business Solutions Consulting

From Concept to Rapid Visualization a Data Analytics Case Study

Glycemic Control of Type 2 Diabetes Mellitus

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

Effects of Withdrawing Diuretic Therapy on Blood Pressure in Mild Hypertension LYNN J. MALAND, B.S. PHARM., LAWRENCE J. LUTZ, M.D., M.S.CM.

Drug Treatment in Type 2 Diabetes with Hypertension

How To Test For Microalbuminuria

Appendix: Description of the DIETRON model

Estimated GFR Based on Creatinine and Cystatin C

Corporate Medical Policy Ambulatory Blood Pressure Monitoring

Cardiovascular Risk in Diabetes

Guideline for Microalbuminuria Screening

ECG may be indicated for patients with cardiovascular risk factors

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness SOGH April

Diabetes and the Kidneys

Understanding Diseases and Treatments with Canadian Real-world Evidence

Albumin and All-Cause Mortality Risk in Insurance Applicants

Evaluation of Diagnostic and Screening Tests: Validity and Reliability. Sukon Kanchanaraksa, PhD Johns Hopkins University

High Blood Pressure and Your Kidneys

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Blood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank

Elevated Blood Pressure Among U.S. Adults with Diabetes,

High Blood Pressure (Essential Hypertension)

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Iron and vitamin D deficiency in preterm babies - a potential programming link to cardiovascular disease in later life

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine

STUDY ON KNOWLEDGE AND ATTITUDE OF BLOOD DONORS TOWARDS BLOOD DONATION IN BIJAPUR DISTRICT Himanshu Dilip Mulay 1, Prakash M.

1990 Life Insurance and Diabetes

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

9/19/2013. Standardizing Preventive Care for Hypertension. About the Speaker. About the Speaker

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Transcription:

IJPSR (2014), Vol. 5, Issue 7 (Research Article) Received on 31 January, 2014; received in revised form, 21 March, 2014; accepted, 26 April, 2014; published 01 July, 2014 SERUM CREATININE LEVEL IN HYPERTENSIVE PATIENTS: A STUDY FROM UTTARAKHAND, INDIA Pooja* 1 and Yashoda Mittal 2 Department of Zoology, Government Post Graduate College 1, Rishikesh, District Dehradun, Uttarakhand, India Kanahiya Lal DAV Post Graduate College Roorkee 2, Haridwar, Uttarakhand, India Keywords: Hypertension, Chronic kidney disease, Creatinine, Renal function Correspondence to Author: Pooja Research Scholar, Govt. Post Graduate College Rishikesh, Uttarakhand, India E-mail: poojabamrara_2007@yahoo.co.in INTRODUCTION: Chronic Kidney diseases or chronic renal diseases are increasingly recognised as a problem worldwide. Incidence of chronic kidney diseases is doubled in last fifteen years. The most common, but not only, causes of chronic kidney diseases are diabetes mellitus and hypertension 1. Hypertension is a chronic medical condition in which the systemic arterial blood pressure is elevated 2. Majority of hypertensive patients are asymptomatic and if left untreated, so many complications develop and become fatal. ABSTRACT: Chronic Kidney diseases are increasingly recognized as a problem worldwide. Incidence of chronic kidney diseases is doubled in last fifteen years. The kidney is both cause and victim of hypertension. Hypertension is a serious risk factor for chronic kidney disease. The purpose of this study was to measure serum creatinine level in hypertensive patients as an indicator of kidney functioning and compared it with normal healthy controls. This study was carried out in Shanti Prapann Sharma Government Hospital, Rishikesh. In present study, the volunteers were selected from General Medicine department of Government hospital Rishikesh from May 2009 to May 2010. A total of 120 volunteers were recruited for this study. Out of them 70 were hypertensive subjects (38 males and 32 females) and 50 were normotensive subjects (27 males and 23 females). Hypertension was defined as per the recommendations of JNC7 th Report. After 12 hours fast the blood samples were collected with the help of trained laboratory technician from all individuals without anticoagulant and centrifuged at 3000 rpm for 5 minutes. The serum was collected in fresh vial and standard method was followed for estimation of serum creatinine. The results conclude that the serum creatinine levels in hypertensive subjects were higher and statistically significant (p < 0.000). It may lead to heart and kidney diseases 3. Many people with chronic kidney diseases do not realize that they have a problem until their kidney functions decreased to more than 25% of normal. Serum creatinine is a most sensitive indicator of impaired kidney functions 4. It is a by- product of muscle energy metabolism that is filtered from the blood by the kidneys and is excreted into the urine 5. Kidney diseases can readily be detectable and treatable so early diagnosis of mild chronic renal QUICK RESPONSE CODE DOI: insufficiency through the determination of serum 10.13040/IJPSR.0975-8232.5(7).2955-59 creatinine is most important for combating morbidity and mortality of hypertension. Article can be accessed online on: Hypertension is now found on its increasing way in www.ijpsr.com urban as well as in rural areas of Uttarakhand 6, 7, 8. DOI link: http://dx.doi.org/10.13040/ijpsr.0975-8232.5(7).2955-59 So this study was conducted to assess the renal functions in patients of hypertension by measuring International Journal of Pharmaceutical Sciences and Research 2955

of serum creatinine and compared it with normal healthy controls in the study area i.e. Rishikesh, Uttarakhand, India. MATERIALS AND METHODS: Study Area: This study was carried out from May 2009 to May 2010 in Departments of General Medicine and Pathology of nearby Shanti Prapann Sharma Govt. Hospital in Rishikesh. The volunteers/subjects were selected from General Medicine Department of Government Hospital, Rishikesh, Uttarakhand, India. The volunteers/subjects were informed by the oral communication regarding the aim and objectives of the present study. Both written and verbal consent have been taken from each of the participant before including study. Ethical issues: Ethical clearance was obtained from the management of Govt. Hospital, Rishikesh (U.K), India. Consent forms were given and duly filled by the volunteers/subjects to seek their permission before been sampled and only volunteers/subjects that agreed by signing the forms that were sampled for this study. Information on clinical signs of patients was obtained using verbal interviews and clinical records of volunteers/subjects. Case Study: Two groups were included in the study as follows: 1. Hypertensive Cases: 70 hypertensive volunteer subjects (38 males and 32 females) with the age range of 31-78 years. 2. Normotensive Controls: 50 normotensive volunteer subjects (27 males and 23 females) with no history of diabetes, hypertension, cardiac or renal diseases with age range of 30-79 years. Hypertension was defined as per the recommendations of JNC7 th Report 9. After 12 hours fast the blood samples were collected with the help of trained laboratory technician of hospital from all individuals without anticoagulant and centrifuged at 3000 rpm for 5 minutes in pathology department. The serum is collected in fresh vial and standard alkaline picrate method has been followed for the estimation of serum Creatinine 10. Serum creatinine was investigated on semi-auto analyzer by using commercially available reagent kit. Statistical Analysis: The collected data were analyzed by Statistical Package for Social Science (SPSS) Software version 16.0. All values were expressed as mean ± S.D. Statistical significance of difference between hypertensive cases and normal healthy control groups was evaluated by using Student s t test. A p-value of < 0.05 was considered as significant. RESULTS: Total 120 subjects comprising of 70 hypertensive cases and 50 controls were included in the present study. Measurements of blood pressure, serum creatinine were done in both the groups. The result of the study is given below as shown in Table 1. TABLE 1: AGEWISE DISTRIBUTION IN CASES AND CONTROLS Age in years Cases Controls Male Female Male Female 30-39 04 02 06 07 40-49 06 07 07 05 50-59 09 10 06 05 60-69 09 03 04 02 70-79 10 10 04 04 Total 38 32 27 23 The hypertensive cases were in the age group of 31-78 years. The mean age of hypertensive subjects was 57.11 years (SD ± 13.48 years) whereas the controls were in the age group of 30-79 and mean age was 50.54 years (SD ± 14.42 years). Out of 70 cases 38 were males and 32 were females and in case of 50 controls 27 were males and 23 were females. International Journal of Pharmaceutical Sciences and Research 2956

The blood pressure was calculated separately as systolic blood pressure and diastolic blood pressure. The mean systolic blood pressure (SBP) of hypertensive subjects was 156.57mmHg (SD ± 24.61 mm of Hg) and that of controls was 113.52 mmhg (SD ± 3.47 mm of Hg). The mean systolic blood pressure was found to be higher in hypertensive subjects than controls (p < 0.05). Mean diastolic blood pressure (DBP) of hypertensive cases was 95.11mmHg (SD ± 7.21 mm of Hg) and that of controls was 73.66 mmhg (SD ± 3.32 mm of Hg). The mean diastolic blood pressure of hypertensive cases was found to be higher than controls (p < 0.05). The results are shown in Table 2 and Figure 1. FIGURE 1: COMPARISION AND MEAN VALUES FOR SBP AND DBP BETWEEN CASES AND CONTROLS TABLE 2: COMPARISON OF MEAN SBP AND MEAN DBP BETWEEN CASES AND CONTROLS Variables Cases Control Mean SD Mean SD t value SBP(mmHg) 156.57 24.61 113.52 3.47 12.267 (S)* DBP(mmHg) 95.11 7.21 73.66 3.32 19.594 (S)* *(S)- statistically siginificant (p < 0.05) The mean serum creatinine level of hypertensive cases was 1.13 (SD ± 0.54 mg/dl) and that of control was 0.78 (SD ± 0.12 mg/dl). The mean serum creatinine of hypertensive cases was higher than normal healthy controls (p < 0.000). The results are shown in Table 3 and Figure 2. TABLE 3: COMPARISON OF MEAN SERUM CREATININE BETWEEN HYPERTENSIVE CASES AND HEALTHY CONTROLS Subjects No. of Cases Serum Creatinine Hypertensive 70 1.13 ± 0.54 Healthy Controls 50 0.78 ± 0.12 Significance p< 0.000 1.2 1 0.8 0.6 0.4 0.2 0 1 Cases 1.13 Controls 0.78 FIGURE 2: COMPARISONS OF MEAN SERUM CREATININE LEVELS IN HYPERTENSIVE CASES AND CONTROLS International Journal of Pharmaceutical Sciences and Research 2957

DISCUSSION: Several studies worldwide have been done on serum creatinine in relation to the risk of chronic kidney disease such as chronic renal failure (CRF) and end stage renal disease (ESRD), but a few studies are in relation to hypertension have been found yet. The observations of our study are discussed as below: In our study serum creatinine was higher in hypertensive cases than normal healthy controls i.e. 1.13± 0.54 mg/dl vs 0.78 ± 0.12 mg/dl, p < 0.000. The creatinine difference was found statistically significant. Similar findings were obtained in multiple risk factor intervention trial (MRFIT), which showed that no relationship was seen between blood pressure at baseline and serum creatinine levels, but in hypertensive patients showed greatest increase in serum creatinine over 6 years follow up 11. Similarly findings of study by Nagah et al in Sudan have shown that mean values of serum creatinine was higher in hypertensive cases than normotensive controls i.e. 141.3 ± 39.0 µ mol/l vs 52.4 ± 18.0 µ mol/l and the difference was statistically significant. They found elevated serum creatinine and protein, in addtion to presence of protein in urine might to be direct effect of hypertension and its related complication on renal function 12. A 9 years follow up study on 897 subjects in hypertension conducted by Rosanky et al, have shown that essential hypertensive subjects had a considerably high rate of turn down in renal function compared with normotensive subjects 13. The results of National Health and Nutrition Examination Survey third (NHANESIII) have shown that serum creatinine level is an indicator of chronic renal disease and was found common and stronlgy related to inadequate treatment of hypertension 14. A study done in Japan by Ishida and co-workers, to know the effect of high BP on renal function by estimating serum creatinine as a marker of kidney functioning and shown that high serum creatinine level are accelerated in hypertensive subjects and in those with proteinuria and especially in those in whom both are present 15. In contrast, study by Kadri et al, showed that serum creatinine was higher in hypertensive subjects than normotensive subjects but the differences were not statistically significant 16. A study done by Wannamethee et al, have shown that elevated serum creatinine was found in 13.8% of hpertensive cases and in 8.6% of normotensive subjects (test of difference, p < 0.001). The serum creatinine levels in male hypertensive cases was higher than male normotensive control i.e. 0.95 ± 0.05 mg/dl vs 0.89 ± 0.05 mg/dl ( p = 0.396). The difference was not found statistically insignificant 17. Another study done by Sarkar and co-workers have shown that serum creatinine was higher in hypertensive cases than normotensive control group i.e. 0.86 ± 3.20 mg/dl vs 0.79 ± 4.01 mg/dl, p = 0.990 but the difference was not statistically significant 18. Present study shows that serum creatinine level was higher in hypertensive cases than normal healthy controls in. So it is conlcuded that hypertensive patients are more prone to develop elevated serum creatinine level and chronic kidney diseases. Hence to prevent the chronic kidney disease and other consequences in hypertension, it is needed to plan the estimation of serum creatinine in daily clinical practice. LIMITATION OF THE STUDY: Small sample size was an important limitation of present study. So large scale cross sectional study may be planned for more accurate assuarance. ACKNOWLEDGEMENT: Authors are very grateful to all the participants and volunteers for the study. The authors wish to thank Dr. Rajiv Hatwal, Chief Medical Superintendent, Government Hospital, Rishikesh (U.K), India for permitting us to conduct this study. The authors felt immense thanks to Physicians, Pathologist and Pathology staff of Govt. Hospital, Rishikesh (U.K), India for their valuable supervision and support throughout the study. REFERENCES: 1. Brenner, Barry M., Floyd C., Rector JR. The kidney, 6 th edition. Philadelphia PA: WB Saunders Company. 1999; p 17-20. International Journal of Pharmaceutical Sciences and Research 2958

2. Carretero OA, Oparil S. Essential hypertension. Part I: definition and aetiology. Circulation. 2000; 101(3): 329-335. 3. Smithon J: Hypertension II. March 2005. Available from: http// www.gp - training/ clinical/ hypert.htm. 4. Pagana and Kathleen Deska. Mosby s manual of diagnostic and laboratory tests. St. Louis MO: Mosby. 1998; Inc. 97-100. 5. Henry JB. Clinical diagnosis and management by laboratory methods. 20 th edition. Philadelphia PA: WB Saunders Company. 2001; p 17-19. 6. Pooja and Yashoda Mittal. Prevalence of Hypertension and its Determinants in an Urban Area of Uttarakhand Asian Journal of Biomedical and Pharmaceutical Science. 2013; 3(21): 12-16. 7. Pooja and Yashoda Mittal. Prevalence of Hypertension among Rural population of Doiwala Block, Dehradun, Uttarakhand, India Recent Research in Science and Technology. 2013; 5 (1): 21-24. 8. Bansal SK, Saxena V, Kandpal SD, Grey WK, Walker RW and Goel D. Prevalence of hypertension and hypertension risk factors in a rural Indian community: A Prospective door to door study. Journal of Cardiovascular Disease Research. 2012; 3(2): 117-123. 9. Chobanian AV, Bakris GL, Black HR. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 th report. JAMA; 289: 2560-2572. Erratum in: JAMA 2003; 290: 197. Comment in: JAMA 2003; 289: 2573-2575. JAMA 2003; 290: 1313-1314; author reply 1314-1315. 10. Henry Canon RJ. DC and Winkelmen J.W. Clinical chemistry, Principles and techniques. 1974; 2: 541-549. 11. Alker G, Neaton J, Cutler JA, Neuwirth R, Cohen JD. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. JAMA. 1992; 268: 3085-3891. 12. Nagah AA Mohammed, H.M. Hamad. Serum creatinine, albumin, and urine protein in hypertensive patients. Indian Journal of Basic & Applied Medical Research. 2012; 1(4): 292-295. 13. Rosansky SJ, Hoover DR, Kig L, Gibson J. The association of blood pressure levels and change in renal function in hypertensive and non-hypertensive subjects. Arch Intern Med. 1990; 150:2073-2076. 14. Coresh J, Wei GL; McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States. Findings from the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001; 161:1207-1216. 15. Ishida K, Ishida H, Narita M, Sairenchi T, Saito Y, Fukutomi H, Takahashi H, Yamagata K and Koyama A. Factors affecting renal function in 119985 adults over three years. QJM. 2001; 94: 541-550. 16. Kadiri S, Ajayi SO. Variability in the relationship between serum creatinine and creatinine clearance in hypertensive and normotensives with normal renal function. Afr J Med Sci. 2000; 29(2): 93-96. 17. Wannamethee SG, Shaper AG, Perry IJ. Serum Creatinine Concentration and Risk of Cardiovascular Disease. Stroke.1997; 28:557-563. 18. Sarkar D, Latif SA, Aich J and Udin MM. Studies on serum Creatinine and Creatinine clearance in hypertensive patients. J Bangladesh Soc Physiol. 2006; 1:19-26. How to cite this article: Pooja and Mittal Y: Serum creatinine level in hypertensive patients: a study from Uttarakhand, India. Int J Pharm Sci Res 2014; 5(7): 2955-59.doi: 10.13040/IJPSR.0975-8232.5 (7).2955-59. All 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License This article can be downloaded to ANDROID OS based mobile. Scan QR Code using Code/Bar Scanner from your mobile. (Scanners are available on Google Playstore) International Journal of Pharmaceutical Sciences and Research 2959